Literature DB >> 7847068

Amyotrophic lateral sclerosis of Guam: the nature of the neuropathological findings.

K Oyanagi1, T Makifuchi, T Ohtoh, K M Chen, T van der Schaaf, D C Gajdusek, T N Chase, F Ikuta.   

Abstract

To elucidate the fundamental differences and similarities of the neuropathological features and etiopathogenesis of the amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia complex (PDC) of Guam, we conducted a topographic, quantitative and histological investigation of tau-containing neurons, neurofibrillary tangles (NFTs), Bunina bodies and ubiquitinated inclusion bodies in 27 non-ALS non-PDC Guamanian subjects, as well as 10 Guam ALS patients, 28 PDC patients, and 5 patients with combined ALS and PDC (ALS-PDC). The topographic distribution of NFTs was basically the same in each disease and also in the non-ALS non-PDC group. There were relatively few, if any, NFTs in non-ALS non-PDC subjects and ALS patients, but there were many, especially in the frontal and temporal cortex, in Guam PDC and ALS-PDC patients. The histological and ultrastructural features of Bunina bodies in Guam ALS and ALS-PDC patients were similar to those reported in classic ALS. The ratio of occurrence of the inclusion in Guam ALS and ALS-PDC patients was similar to that reported so far in classic ALS. Ubiquitinated skein-like inclusion bodies were observed in the spinal anterior horn cells in Guam ALS and ALS-PDC patients. These findings indicate that classic ALS does exist on Guam, that NFTs in Guam ALS patients are merely a background feature widely dispersed in the population, that the mechanism of neuronal degeneration of Guam ALS is basically different from that of PDC, and that Guam ALS occurs initially are classic ALS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7847068     DOI: 10.1007/bf00389491

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features.

Authors:  A HIRANO; L T KURLAND; R S KROOTH; S LESSELL
Journal:  Brain       Date:  1961-12       Impact factor: 13.501

2.  Alzheimer's neurofibrillary changes. A topographic study.

Authors:  A HIRANO; H M ZIMMERMAN
Journal:  Arch Neurol       Date:  1962-09

3.  Ubiquitin-immunoreactive filamentous inclusions in anterior horn cells of Guamanian and non-Guamanian amyotrophic lateral sclerosis.

Authors:  S Matsumoto; A Hirano; S Goto
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex.

Authors:  A Hirano; H M Dembitzer; L T Kurland; H M Zimmerman
Journal:  J Neuropathol Exp Neurol       Date:  1968-04       Impact factor: 3.685

5.  Parkinsonism-dementia in a Filipino migrant: a clinicopathologic case report.

Authors:  K M Chen; T Makifuchi; R M Garruto; D C Gajdusek
Journal:  Neurology       Date:  1982-11       Impact factor: 9.910

6.  Ultrastructure of the Bunina bodies in anterior horn cells of amyotrophic lateral sclerosis.

Authors:  M Tomonaga; M Saito; M Yoshimura; H Shimada; H Tohgi
Journal:  Acta Neuropathol       Date:  1978-05-24       Impact factor: 17.088

7.  Amyotrophic lateral sclerosis. A comparison of Guam and classical cases.

Authors:  A Hirano; N Arumugasamy; H M Zimmerman
Journal:  Arch Neurol       Date:  1967-04

8.  Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies.

Authors:  A Hirano; N Malamud; T S Elizan; L T Kurland
Journal:  Arch Neurol       Date:  1966-07

9.  Neurofibrillary change on Guam.

Authors:  L Chen
Journal:  Arch Neurol       Date:  1981-01

10.  Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.

Authors:  S K Shankar; R Yanagihara; R M Garruto; I Grundke-Iqbal; K S Kosik; D C Gajdusek
Journal:  Ann Neurol       Date:  1989-02       Impact factor: 10.422

View more
  7 in total

Review 1.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

Review 2.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

Review 3.  Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: an update.

Authors:  K Oyanagi; M Wada
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

4.  Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection.

Authors:  Xiaochuan Wang; Julie Blanchard; Inge Grundke-Iqbal; Jerzy Wegiel; Han-Xiang Deng; Teepu Siddique; Khalid Iqbal
Journal:  Acta Neuropathol       Date:  2013-10-18       Impact factor: 17.088

5.  Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis.

Authors:  Dunlop Ra; Banack Sa; Bishop Sl; Metcalf Js; Murch Sj; Davis DA; Stommel Ew; Karlsson O; Brittebo Eb; Chatziefthimiou Ad; Tan Vx; Guillemin Gg; Cox Pa; Mash Dc; Bradley Wg
Journal:  Neurotox Res       Date:  2021-02-06       Impact factor: 3.911

6.  Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain.

Authors:  Paul Alan Cox; David A Davis; Deborah C Mash; James S Metcalf; Sandra Anne Banack
Journal:  Proc Biol Sci       Date:  2016-01-27       Impact factor: 5.349

7.  Dysfunction of Protein Quality Control in Parkinsonism-Dementia Complex of Guam.

Authors:  Bert M Verheijen; Kiyomitsu Oyanagi; Fred W van Leeuwen
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.